Rapid7 Vulnerability & Exploit Database

VMSA-2018-0002: ESXi Branch Target Injection (CVE-2017-5715)

Free InsightVM Trial No Credit Card Necessary
2024 Attack Intel Report Latest research by Rapid7 Labs
Back to Search

VMSA-2018-0002: ESXi Branch Target Injection (CVE-2017-5715)

Severity
2
CVSS
(AV:L/AC:M/Au:N/C:P/I:N/A:N)
Published
01/04/2018
Created
07/25/2018
Added
01/10/2018
Modified
11/27/2024

Description

Systems with microprocessors utilizing speculative execution and indirect branch prediction may allow unauthorized disclosure of information to an attacker with local user access via a side-channel analysis.

Solution(s)

  • vmware-esxi55-upgrade-7618464
  • vmware-esxi60-upgrade-6856897
  • vmware-esxi65-upgrade-7273056

insightVM

Advanced vulnerability management analytics and reporting.
Key Features
  • Lightweight Endpoint Agent
  • Live Dashboards
  • Real Risk Prioritization
  • IT-Integrated Remediation Projects
  • Cloud, Virtual, and Container Assessment
  • Integrated Threat Feeds
  • Easy-to-Use RESTful API
  • Automation-Assisted Patching
  • Automated Containment
Free InsightVM Trial View All Features

With Rapid7 live dashboards, I have a clear view of all the assets on my network, which ones can be exploited, and what I need to do in order to reduce the risk in my environment in real-time. No other tool gives us that kind of value and insight.

– Scott Cheney, Manager of Information Security, Sierra View Medical Center

;